Health Technology/clinical-trials

Prospective Cohort Study Evaluates Machine Learning Risk Stratification for Extrahepatic Metastasis in Hepatocellular Carcinoma — Real-World Implementation Data

247 Health News Editorial

·

15 Apr 2026

·

4 min read

·clinical-trials

A large prospective study evaluates machine learning-guided surveillance for detecting extrahepatic metastasis in hepatocellular carcinoma patients. The research examines real-world implementation of personalised risk stratification strategies across multiple centres.

Originally reported by ClinicalTrials.gov

References

  1. 1.Chen, J. H., & Asch, S. M. (2017). Machine learning and prediction in medicine—beyond the peak of inflated expectations. New England Journal of Medicine, 376(26), 2507-2509. https://doi.org/10.1056/NEJMp1702071
  2. 2.European Association for the Study of the Liver. (2018). EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology, 69(1), 182-236. https://doi.org/10.1016/j.jhep.2018.03.019
  3. 3.Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021). Hepatocellular carcinoma. Nature Reviews Disease Primers, 7(1), 6. https://doi.org/10.1038/s41572-020-00240-3
  4. 4.Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018). Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology, 68(2), 723-750. https://doi.org/10.1002/hep.29913
  5. 5.Rajkomar, A., Dean, J., & Kohane, I. (2019). Machine learning in medicine. New England Journal of Medicine, 380(14), 1347-1358. https://doi.org/10.1056/NEJMra1814259
  6. 6.Singal, A. G., Lampertico, P., & Nahon, P. (2020). Epidemiology and surveillance for hepatocellular carcinoma: New trends. Journal of Hepatology, 72(2), 250-261. https://doi.org/10.1016/j.jhep.2019.08.025
  7. 7.Therapeutic Goods Administration. (2023). Software as Medical Device: Guidance for manufacturers. TGA Guidelines. https://www.tga.gov.au/resources/resource/guidance/software-medical-device-guidance-manufacturers
  8. 8.Tongji Hospital. (2024). Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07444905
  9. 9.Topol, E. J. (2019). High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine, 25(1), 44-56. https://doi.org/10.1038/s41591-018-0300-7
  10. 10.Vogel, A., Meyer, T., Sapisochin, G., Salem, R., & Saborowski, A. (2022). Hepatocellular carcinoma. The Lancet, 400(10360), 1345-1362. https://doi.org/10.1016/S0140-6736(22)01200-4
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service